Automated PCR detection of BRAF mutations in colorectal adenocarcinoma: a diagnostic test accuracy study

被引:22
作者
Colling, Richard [1 ]
Wang, Lai Mun [1 ]
Soilleux, Elizabeth [1 ,2 ]
机构
[1] Oxford Univ Hosp NHS Trust, Dept Cellular Pathol, Oxford, England
[2] Univ Oxford, Nuffield Div Clin Lab Sci, Oxford, England
关键词
LYNCH SYNDROME; CANCER;
D O I
10.1136/jclinpath-2015-203345
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background Testing for BRAF mutations in colorectal carcinoma (CRC) is important in the screening pathway for Lynch syndrome and is of prognostic value to guide management. This is a diagnostic accuracy study of the Idylla system, a novel and automated alternative PCR system. Methods 100 consecutive formalin-fixed, paraffin-embedded CRC resection cases were tested for BRAF mutations using the Idylla automated platform and compared with standard (Cobas) PCR. Results The sensitivity of the Idylla BRAF test was 100% and the specificity was 96%. Only one discordant Idylla positive/standard PCR negative result occurred and on Droplet Digital PCR demonstrated a mutation not identified by traditional PCR in this case. Conclusion This study has validated the Idylla system for BRAF testing in CRC and demonstrated a possibly greater sensitivity, in addition to cost effectiveness and shorter turnaround time, when compared with standard PCR.
引用
收藏
页码:398 / 402
页数:5
相关论文
共 21 条
[1]  
[Anonymous], 2014, STANDARDS DATASETS R
[2]  
[Anonymous], NCCN CLIN PRACTICE G
[3]  
Bio-Rad Laboratories, QX200 DROPL DIG PCR
[4]   Simple nomograms to calculate sample size in diagnostic studies [J].
Carley, S ;
Dosman, S ;
Jones, SR ;
Harrison, M .
EMERGENCY MEDICINE JOURNAL, 2005, 22 (03) :180-181
[5]   Screening for Lynch syndrome and referral to clinical genetics by selective mismatch repair protein immunohistochemistry testing: an audit and cost analysis [J].
Colling, Richard ;
Church, David N. ;
Carmichael, Juliet ;
Murphy, Lucinda ;
East, James ;
Risby, Peter ;
Kerr, Rachel ;
Chetty, Runjan ;
Wang, Lai Mun .
JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (12) :1036-1039
[6]   BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer [J].
Deng, GR ;
Bell, I ;
Crawley, S ;
Gum, J ;
Terdiman, JP ;
Allen, BA ;
Truta, B ;
Sleisenger, MH ;
Kim, YS .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :191-195
[7]  
Devogelaere B, 2013, CANC RES S, V73, P4213
[8]   Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis [J].
Gallego, Carlos J. ;
Shirts, Brian H. ;
Bennette, Caroline S. ;
Guzauskas, Greg ;
Amendola, Laura M. ;
Horike-Pyne, Martha ;
Hisama, Fuki M. ;
Pritchard, Colin C. ;
Grady, William M. ;
Burke, Wylie ;
Jarvik, Gail P. ;
Veenstra, David L. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18) :2084-U145
[9]   Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer [J].
Giardiello, Francis M. ;
Allen, John I. ;
Axilbund, Jennifer E. ;
Boland, C. Richard ;
Burke, Carol A. ;
Burt, Randall W. ;
Church, James M. ;
Dominitz, Jason A. ;
Johnson, David A. ;
Kaltenbach, Tonya ;
Levin, Theodore R. ;
Lieberman, David A. ;
Robertson, Douglas J. ;
Syngal, Sapna ;
Rex, Douglas K. .
GASTROINTESTINAL ENDOSCOPY, 2014, 80 (02) :197-220
[10]   Molecular Alterations and Biomarkers in Colorectal Cancer [J].
Grady, William M. ;
Pritchard, Colin C. .
TOXICOLOGIC PATHOLOGY, 2014, 42 (01) :124-139